BTI® - Leader in Regenerative Medicine and Oral Implantology!
Synca is proud to announce its exclusive partnership with BTI® Biotechnology Institute in Canada. BTI® Biotechnology Institute is a Spanish multinational company specialising in biomedicine and biotechnology whose activity focuses on two areas:
Regenerative Medicine and Oral Implantology.
BTI® is carrying out research since 1995 & regarded worldwide as a scientific pioneer in Regenerative Medicine for the development and patents of the technology of plasma rich in growth factors Endoret® (prgf®) in different fields of medicine. In the area of Oral Implantology, BTI® developed an Implant System which stands out internationally for its quality, innovation and versatility.
More than 5000 m
2 devoted to training, clinical practice and research.
BTI® trains in order to optimise the clinical results
- Specific training aimed at different medical specialities.
- More than 40 scientific collaboration agreements with universities and research institutes all over the world.
- More than 1200 students per year of all nationalities.
Translational research: knowledge acquired in the laboratory applied to clinical practice
Collaboration with experts from different countries in different fields of medicine for the development of clinically effective protocols.
More than 150 indexed scientific publications back the effectiveness and biosafety of ENDORET®
- 20% of the workforce dedicated to research.
- More than 15 years of research in tissue regeneration.
